Flutamide in treatment of benign prostatic hypertrophy.

Urology
N N Stone

Abstract

A multicenter, randomized, double-blind study was undertaken to evaluate the efficacy of the antiandrogen flutamide in treating patients with urinary obstruction caused by benign prostatic hypertrophy (BPH). Patients were randomized to either flutamide (750 mg/d) or a placebo. Prostate size (measured by ultrasound), uroflow, and symptomatology were assessed in all patients. Of the 84 patients entered in the study, 30 receiving placebo have, to date, reached twelve weeks and 4 have reached twenty-four weeks. Twenty-eight patients receiving flutamide have reached twelve weeks, while 8 have reached twenty-four weeks. At twenty-four weeks, a 41 percent median decrease in prostate volume and a 46 percent increase in full-bladder uroflow was observed in patients receiving flutamide; no significant changes in prostate volume or uroflow occurred in patients receiving placebo. However, significant symptomatic improvements were noted in both groups. Only 4 patients (11%) had significant adverse reactions to flutamide; these reactions included breast pain and diarrhea. No cases of impotence occurred. It was concluded that flutamide may be a safe and effective drug for the treatment of symptomatic BPH.

References

Jun 1, 1987·The Journal of Clinical Endocrinology and Metabolism·J L GabriloveM Droller

❮ Previous
Next ❯

Citations

Nov 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·F SciarraF Di Silverio
Jan 16, 1999·Baillière's Clinical Endocrinology and Metabolism·Y S ZhuJ Imperato-McGinley
Jan 12, 1995·The New England Journal of Medicine·J E Oesterling
Nov 1, 1994·British Journal of Urology·M al-RimawiM A Johnson
Feb 14, 2007·The Journal of Urology·Nelson N Stone, Richard G Stock
Jun 1, 1995·Scandinavian Journal of Urology and Nephrology·T U EliassonJ E Damber
May 1, 1991·The Journal of Urology·M K Terris, T A Stamey
Aug 1, 1994·Clinical Endocrinology·F H Schröder
Apr 1, 1997·The Annals of Pharmacotherapy·M Lee, R Sharifi
Jul 1, 1995·Disease-a-month : DM·W D Steers, B Zorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.